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Abstract 
Purpose: To investigate whether the total triterpenoids extracted from Psidium Guajava leaves 
(TTPGL) attenuate the development of diabetic peripheral neuropathy in rats by regulating the NF-κB 
pathway of the inflammatory process and its signaling mediators. 
Methods: All the Sprague Dawley rats used were maintained in a clean environment on a 12 h light/12 
h dark cycle. High-fat feeding and intraperitoneal injection of 40 mg/kg streptozotocin (STZ) were used 
to induce diabetes in the rats. The rats were randomly divided into 5 groups: diabetic mellitus (DM) 
group; TTPGL - 30 group, TTPGL - 60 group and TTPGL - 120 group treated by intragastric 
administration (i.g) with 30, 100 and 120 mg/kg/day TTPGL, respectively. The well-established drug, 
rosiglitazone (RSG, 3 mg/k/d, i.g.), was used as positive control. Normal rats served as control group. 
Nerve conduction velocity and sensitive tests were measured on weeks 1, 4 and 8. After 8 weeks 
administration, expression of pro-inflammatory molecules (TNF - α, IL - 6 and iNOS) and tissue proteins 
(Akt, IKKα, and NF – κB - p65) were evaluated to assess biochemical changes.  
Results: Compared to DM group, TTPGL (especially 120 mg / kg dose) treatment improved (p < 0.05) 
physical functions and provided neuronal protection in high - fat/streptozotocin - induced peripheral 
neuropathy rats. We found that the expressions of several pro - inflammatory factors such as tumor 
necrosis factor - α (TNF - α), IL - 6 and inducible nitric oxide synthase (iNOS) were highly suppressed (p 
< 0.05 or p < 0.01) by TTPGL in sciatic nerve. Mechanism analysis indicated that the ameliorative effect 
of TTPGL, in part, is through suppression of the expression of pro - inflammatory cytokines by NF - κB 
pathway mediation. 
Conclusion: TTPGL offers a potential therapeutic approach for the treatment of diabetic peripheral 
neuropathy.  
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Psidium guajava Linn., commonly known as 
guava, has been naturalized in South - East Asia 
[1]. In oriental regions, such as Taiwan, guava 
leaves is boiled and the extract is used in folk 
medicine for the treatment of diabetes [2] but few 
of the extract has been investigated for their 
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preclinical or clinical efficacy. Psidium guajava 
Linn. (Myrtaceae) is a small evergreen tree and 
its leaves are short-petiolate with the blade oval 
with prominent pinnate veins. Leaves of this plant 
have been reported to contain several 
compounds such as triterpenoids [1] and 
flavonoids [3]. Recent tropical relevance studies 
have shown that the leaves of Psidium guajava 
have been used for the treatment of a number of 
diseases, e.g. as an anti - inflammatory, for 
diabetes, pain relief and anti - pyretic. Moreover, 
previous phytochemical investigations had 
demonstrated that triterpenoids are the principle 
compounds isolated from the leaves [4]. As a 
continuing research of this potential drug for 
diabetic complications, we conduct this study on 
5 known triterpenes: Asiatic acid, Maslinic acid, 
Corosolic acid, Oleanolic acid, and Ursolic acid. 
Many of the pathophysiological pathways of 
diabetic neuropathy focused on inflammation and 
its mechanisms appear to converge upon the 
activation of NF - κB in diabetic neuropathy [5,6]. 
In addition to modulating of pro - inflammatory 
responses, NF - κB causes the transcription of 
pro - inflammatory mediators such as interleukin 
- 6 (IL - 6), tumor necrosis factor - α (TNF - α) 
and inducible nitric oxide synthase (iNOS) [7]. It 
is reported that Asiatic acid and Oleanolic acid 
possess anti - inflammatory activities [8,9]. 
Therefore, it is essential to investigate whether 
TTPGL has protective effect on DPN by 
suppressing NF - κB pathway and thus inhibits 




Chemicals and reagents 
 
Protein kinase B (Akt), inhibitory κB kinase alpha 
(IKKα) and phosphor - IKKα and NF - κB - p65, 
horse radish per - oxidase (HRP) - conjugated 
antirabbit IgG were purchased from Cell 
Signaling Technology, Inc. (Beverly, MA, USA). 
Other reagents were purchased from Sigma - 
Aldrich (St. Louis, MO, USA) unless indicated 
elsewhere. 
 
Extraction and isolation compounds of 
TTPGL 
 
The leaves of Psidium guajava were collected 
from their natural habitat in Guangzhou, 
Guangdong, in October of 2007. The plant was 
authenticated by Prof. Shu - Yuan Li 
(Guangdong Pharmaceutical University, 
Guangzhou, China). A voucher specimen (no. 
2007101801) was deposited at the herbarium of 
Institute of Traditional Chinese Medicine & 
Natural Products, Jinan University. 
 
The air-dried leaves of P. guajava (5.0 kg) were 
powdered and percolated with 85 % (v/v) EtOH 
at room temperature for three times (3 × 35 
liters). After removing the solvent, the alcohol 
extract (110 g) was suspended in H2O and 
partitioned successively by petroleum acetone 
(PA) to obtain the PA extract (88 g) and water 
extract (22 g), respectively. The PA extract (88 g) 
was separated by silica gel (200 - 300 mesh) CC 
and eluted with TFA - MeOH to obtain fractions. 
Fractions were separated by silica gel column 
with gradient mixtures of MeOH - TFA as eluents 
to yield subfractions. The PA extract (88.0 g) was 
separated by silica gel (200 - 300 mesh) CC and 
eluted with MeOH - TFA to obtain 8 fractions (C1 
- C8). Fractions were subjected to silica gel 
column eluted with mixtures of MeOH - TFA 
(8500:1; v/v) to yield compounds 1 (120 mg, 98 
%), 2 (120 mg, 98 %), 3 (120 mg, 98 %), 4 (150 
mg, 98 %) and 5 (200 mg, 98 %). 
 
Induction of hyperglycemia in rats and blood 
glucose measurement  
 
Adult male Sprague Dawley rats (130 - 140 g, 
animal quality certificate number SCXK 2013 - 
0002) were maintained under standard condition 
(a constant temperature on a clean environment 
in a 12 h light/12 h dark cycle). All procedures 
were carried out in accordance with the 
principles of U.S. National Institutes of Health 
guidelines [10]. All study protocols were 
approved by the local government committee for 
animal research (approval ref no. 
20140110103118).  The rats were fasted for 12 h 
prior to injection, rats were injected with STZ (40 
mg/kg, dissolved in 0.1 mmol/L sodium citrate 
buffer, pH 4.5) intraperitoneally, while the control 
group rats were injected with the vehicle citrate 
buffer. One week later, the rats with blood 
glucose above 11.1 mmol/L were considered 
diabetic and selected for further pharmacological 
studies [11]; secondly, animals were fed their 
respective diets until the end of the study as 
described: diabetic rats were fed with a high - fat 
diet (consisting of 70 % standard laboratory diet, 
15 % carbohydrate, 10 % lard and 5 % yolk 
powder) while the healthy rats were fed with 
normal chow. Blood samples obtained from the 
tail vein of rats were monitored for glucose once 
a week using reagent strips with a glucometer 
(Onetouch Ultra 2, Johnson & Johnson, Milpitas, 
CA, USA). 
 
Experimental animal groups 
 
Diabetic rats were randomized into 5 groups of 
10 animals each and were still fed with a high - 
fat diet, namely DM (untreated diabetic rats) 
group, TTPGL - 30 (30 mg/kg/d, i.g.) group, 
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TTPGL - 60 (60 mg/kg/d, i.g.) group, TTPGL - 
120 (120 mg/kg/d, i.g.) group and RSG (3 
mg/kg/d, i.g.) group (as a hypoglycemic positive 
control). Normal rats served as control group (n = 
10). 8 weeks were designed for each group. The 
samples from the rats were collected during 
anesthesia and finally the rats were sacrificed. 
 
Nerve function measurement 
 
We measured MNCV and SNCV in all rats at 1, 4 
and 8 weeks after treatment in rats. MNCV was 
calculated by subtracting the distal latency from 
the proximal latency, and recorded in meters per 
second as the ratio of the distance in millimeters. 
SNCV was measured in the digital nerve to the 
second toe, using the smallest intensity current 
that resulted in an amplitude response, and was 
recorded in meters per second as the ratio of 
distance between stimulating and recording 
electrodes. [12,13] 
 
To determine the thermal response latency, rats 
were placed within a plexi glass chamber and 
allowed to acclimatize for at least 20 min. A 
thermal stimulation meter from ChengDu 
Technology & Market Co., LTD. (Chengdu, 
China) was used. The device was activated after 
placing the stimulator directly beneath the tail. 
Tail flick latency in response to the radiant heat 
(a heating rate of 1.3 °C per second, cut - off 
time of 16 s for rats) was recorded. At least three 
readings per rat were taken at 15 min intervals, 
and the average was calculated. 
 
Immunofluorescence (IF) staining 
 
We fixed and embedded sciatic nerves in paraffin 
with transverse section. The paraffin sections, 
cut at 5 μm, were deparaffinized in xylene and 
rehydrated in a series of graded alcohols to 
distilled water. Antigen retrieval was then 
performed in 10 mmol/L citrate, pH 6.0, using 
1100 - W microwave oven for 3 min at high 
power and 12 min at 50 % power. The slides 
were allowed to cool at room temperature. 
Tissues were then incubated for 10 min in 0.3 % 
hydrogen peroxide to block endogenous 
peroxidase activity. The slices were then washed 
for 5 min in PBS and were incubated in 0.1 % 
Triton X - 100 and 5 % goat serum for 30 min. 
Tissues were then incubated with primary 
monoclonal antibody raised against IL - 6 
(1:100), TNF (1:100), iNOS (1:50) overnight at 4 
°C in a humidified chamber. Following extensive 
washing, the slices were incubated with 
fluorescein conjugated secondary antibody at 
room temperature for 1.5 h [14]. The nuclei were 
counterstained using 4’ - 6’diamidino - 2 - 
phenylindole (DAPI). All immunofluorescence 
staining were performed in replicates on 3 sciatic 
nerves. The sections were examined under a 
Zeiss Axiophot fluorescence microscope. To 
examine inflammatory cytokines infiltration in the 
sciatic nerve, randomly 15 - 20 fields or focuses 
from each animal were observed and analyzed 
by Image J (version 1.46 m) software. 
 
Western blotting assay 
 
Protein lysates were obtained by homogenizing 
sciatic nerves with lysis buffer containing 1 % 
Triton X - 100, 150 mmol/L NaCl, 1 mmol/L 
EDTA, 2.5 mmol/L sodium pyrophosphate, 1 
mmol/L β - glycerophosphate, 1 % Na3VO4, 1 
μg/mL leupeptin, 1 μg/mL aprotinin and 20 
mmol/L Tris (pH 7.5). Equal amounts of 40 μg 
proteins were separated by SDS - PAGE (10 %) 
and transferred to a nitrocellulose membrane 
(Pall Life Sciences, Florida, USA). After blocking 
with 3 % bovine serum albumin, membranes 
were incubated with primary antibodies against 
Akt, IKKα, NF - κB - p65, phosphor - Akt, 
phosphor - IKKα, and phosphor - NF - κB - p65 
for 12 h at 4 °C. After washing, membranes were 
then incubated with anti - rabbit IgG conjugated 
to HRP (1:1000 dilution) at room temperature for 
1 h. Membranes were washed thrice, visualized 
with Immobil on Western HRP Substrate, and 
scanned with a Kodak Digital Imaging System 
(Gel Logic 2200 Pro; Kodak, Tokyo, Japan). β - 
actin expression was set as internal control and 





Statistical analysis was performed using SPSS 
19.0 software (SPSS, Chicago, USA). Data are 
expressed as mean ± SEM. Multiple groups were 
compared using one - way analysis of variance 
followed by Tukey HSD post hoc comparison. P 




The structures of compound 1 - 5 were identified 
by comparing the 1H NMR and 13C NMR spectral 
data with previous literature reports. Principal 
components are shown in Table 1. 
 
Effect of TTPGL on fasting blood glucose 
(FBG) 
 
Levels of FBG in serum are shown in Fig 1. It 
showed significant differences (p < 0.05) in the 
TTPGL - 60, TTPGL - 120 and RSG groups 
compared to the DM group. 
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   Table 1: Characterization of principal components in TTPGL by HPLC 
 
No. Chemical Molecular formula 
Molecular 
weight Content (%) 
1 Asiatic acid C30H48O5 488 18 
2 Maslinic acid C30H48O4 472 12 
3 Corosolic acid C30H48O4 472 36 
4 Oleanolic acid C30H48O3 456 3 
5 Ursolic acid C30H48O3 456 8 
 
 
Fig 1: Effect of TTPGL on FBG. * p < 0.05 vs. DM . #p 
< 0.05 vs. Control. 8 rats in each group. mM = mmol/L 
 
Effect of TTPGL on neurological function 
 
The definition of DPN may include a focused 
neurological examination or nerve conduction 
studies, or, all of these [5]. As shown in Fig. 2, 
within 8 weeks of the onset of diabetes induced 
by STZ, a severe peripheral neuropathy 
developed. Rats with 8 - week duration of high - 
fat/STZ diabetes had development of MNCV (16 
%) and SNCV (9 %) deficits compared with 
Control. In contrast, after 8 weeks of TTPGL - 
120/RSG treatment, all nerve conduction 
velocities demonstrated a marked improvement 
(p < 0.05) (Fig 2A and B). In addition, compared 
to DM group, treatment of TTPGL - 120 and RSG 
groups markedly (p < 0.05) produced a reduction 
in thermal latency (Fig. 2C). 
 
Effect of TTPGL on sciatic nerve TNF - α, IL - 
6 and iNOS expression 
 
Based on findings above, using IF staining, we 
confirmed the inhibitory effect of TTPGL on 
inflammatory mediators. Compared to the 
Control, DM group exhibited significant (p < 0.05) 
increase in fluorescence intensity, while 
treatment with TTPGL decreased the 
fluorescence intensity. Those micrographs 
indicated that TTPGL inhibited the production of 
the inflammatory mediators TNF - α, IL - 6 and 
iNOS at the dose of 60 or 120mg/kg, 
respectively. 
 
Fig 2: Effect of TTPGL on neurological functions. Nerve function test was performed at the 1st, 4th, 8th week. 
Variables of peripheral nerve function in nondiabetic and diabetic rats maintained with or without TTPGL or RSG 
treatments. MNCV (A), SNCV (B) and Thermal response latency test (C). *p < 0.05 vs. DM. # p < 0.05 vs. Control. 
8 rats in each group 
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Quantitative analysis of inflammatory 
expressions are shown in Fig. 3. RSG effects on 
high - fat diet/STZ induced diabetic rats is similar 
to that of TTPGL (60 or 120 mg/kg). These data 
are in accordance to our previous hypothesis that 
TTPGL could be developed into a protective 
agent against NF - κB - mediated expression of 
neuroinflammatory mediators. 
 
Effect of TTPGL on NF - κB activation via the 
Akt/IKKα pathway 
 
As shown in Fig. 4, the experiments revealed 
that the constitutive NF - κB cascade in sciatic 
nerve of diabetic rats was significantly (p < 0.05) 
increased when compared with that of the 
Control. TTPGL dose - dependently decreased 
(p < 0.05 or p < 0.01) the phosphorylation levels 
of Akt (Fig. 4A), IKKα (Fig. 4B) and which 
subsequently suppressed phosphorylation levels 
of NF - κB - p65 (Fig. 4C). RSG as well as 
TTPGL (60mg/kg, 120 mg/kg) significantly (p < 
0.05) inhibited the phosphorylation levels of Akt, 
IKKα and NF - κB - p65 than that of the DM 
group (Fig. 4). Furthermore, TTPGL at dose of 
120mg/kg exhibited extremely significant (p < 
0.01) decrease in protein expression. These 
findings suggested that TTPGL suppresses the 
NF - κB - p65 activation and regulate NF - κB - 




Fig. 3: Immunofluorescence evaluation of sciatic nerves. Transverse section was conducted in this study, Left: 
Immunofluorescent micrographs showing TNF - α, iNOS and IL - 6 expressions in each group. The location of 
neuroinflammatory mediators (green) were examined by immunofluorescence staining and nuclei were stained 
with DAPI (blue). Bar, 50 μm. Right: Quantitative analysis of neuroinflammatory mediator expressions according 
to immunofluorescent micrographs, respectively. *p < 0.05 vs. DM; # p < 0.05 vs. control 
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Fig. 4: Evaluation of protein expression by using western blot. (A) Left: The expression of p - Akt and Akt; Right: 
Quantitative analysis of p - Akt / Akt. (B) Left: The expression of p - IKKα and IKKα; Right: Quantitative analysis 
of p - IKKα / IKKα. (C) Left: The expression of p - p65 and p65; Right: Quantitative analysis of p - p65 / p65. **p < 




The findings reported herein show that long - 
term TTPGL treatment exerted protective effects 
in high - fat/STZ relevant model for DPN in vivo. 
Through a combination of biochemical and 
histological results, TTPGL plays a role in 
suppressing the expression of inflammatory 
mediators. Mechanistic studies suggested that 
TTPGL significantly ameliorates DPN through 
negatively regulating Akt/IKKα mediated NF - κB 
pathway. 
 
In present studies, treatment with TTPGL - 120 
ameliorated the deficits in MNCV, SNCV versus 
the DM group. The sensorimotor alteration, is 
one of the debilitating features of diabetic 
neuropathy in which nerve sensitization and 
inflammation are the commonly observed 
mechanisms [15,16]. The favorable effects of 
TTPGL on nerve - functional deficits may be due 
to its lightly hypoglycemic effect and its effect on 
inflammatory infiltration. The exact principle 
responsible for the hypoglycemia and 
amelioration effect on DPN were not investigated 
in the current study. Moreover, further studies 
would be required to determine the exact 
mechanism(s) and site of action of the extract. 
 
Inflammatory cytokines which have been 
observed to contribute to the development of 
neuropathy and neuropathic pain in diabetes 
includes TNF - α and IL - 6 [17]. Treatment with 
TTPGL was able to attenuate the increased 
levels of TNF - α and IL - 6 in treated group 
which might have aided in decreasing 
inflammatory damage found in sciatic nerves. It 
is known that NF - κB activation induces the 
expression of iNOS, an enzyme induced during 
inflammatory conditions which specifically binds 
to COX-2 and S - nitrosylates to enhance COX - 
2 activity [18]. TTPGL - 120 treatment inhibited 
the induction of iNOS which may have further 
decreased COX - 2 activity as well as 
inflammatory damage in neurons. 
 
In this study, we observed TTPGL ameliorative 
effect and investigated correlated underlying 
mechanisms in the diabetes peripheral 
neuropathy rats. The NF - κB signaling cascade 
interacts with several parallel pathways including 
the signaling cascades initiated by 
phosphatidylinositol 3 - kinase PI3K and Akt 
[19,20]. Akt, functioning as a key downstream 
target of PI3K, has been suggested to function 
as an IKK (IκB kinase) kinase [21]. Western blot 
analysis showed that the expressions of p - Akt 
and p - IKKα in the DM group were significantly 
higher (p < 0.01) than those in the Control. In 
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addition, the increased expressions of p - Akt 
and p - IKKα after STZ treatment could be 
attenuated by TTPGL administration. These 
results were indicated that TTPGL exerts 
ameliorative effect in DPN rats associated with 




The findings provide the first direct evidence that 
TTPGL effectively decreased the release of 
inflammatory mediators in vivo. The efficacy of 
TTPGL, at least in part, may be due to the 
combined modulation of levels of NF - κB and 
inflammatory mediators as seen in our study. 
Interactions among TTPGL and other 
inflammatory mediators implicated in the 
pathogenesis of DPN also need to be explored. 
However, this work provides rationale for the 
evaluation of TTPGL in easily accessible natural 
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